The placebo-controlled, double-blind, randomised Phase I trial involved 100 healthy participants.

Activation of immune blood biomarkers from interferon gamma pathway distinguished long-term survivors (>=2 years) ...

The new approach brings research directly to participants using decentralised and patient-centric digital engagement tools.

By Nancy Lapid Jan 22 (Reuters) - Many patients using highly effective GLP-1 drugs like Wegovy may not regain lost weight ...

In a new pilot feasibility study, researchers from Mayo Clinic, the University of Washington School of Medicine, the ...

Explore the unique mechanisms of bispecific antibodies and their rapid availability compared to CAR T-cell therapies in cancer treatment.

As clinical research evolves at an unprecedented pace, it’s important that physicians understand how emerging trends may ...

Cohort 4 data demonstrated positive safety and efficacy results, including additional clinical benefit observed following ...

Corvus Pharmaceuticals, Inc. shares are up on solid soquelitinib AD phase 1 data: 75% hit EASI 75 at 200 mg BID, many ...

SHANGHAI, May 23, 2025 /PRNewswire/ -- Mabwell (688062.SH), an innovation-driven biopharmaceutical company with entire industry chain, announced multiple clinical research results to be presented at ...

Patients’ financial resources affect their enrollment in oncology clinical trials to a greater degree than traditional ...